ISLAMABAD: Nearly 11% of the country’s population has developed coronavirus immunity.
According to a press release issued on Friday, these estimates were reported in the study presented in July through the Academy of Health Services in collaboration with several components that added AKU and with the technical assistance of the World Health Organization (WHO). The press release indicated that the studies were part of WHO’s review of unity, which is being conducted in 25 other countries.
“It is estimated that almost 11% of Pakistanis have developed protective immunity across Pakistan. This means that one in ten Pakistanis has developed antibodies opposed to the Covid-19 virus in his blood,” he said.
The ministry said the study found that HIV has a greater prestige in urban spaces than in rural ones. He also claimed that those who had been in contact with a positive user at Covid-19 were more likely to have antibodies in their blood.
“It was not more unusual in young adults and particularly less unusual in young people and older adults,” he said. He added that the effects of the studies supported other studies that knew that older adults were at their best in the face of the threat of a imaginable wave of time.
“He also found in the study that the use of mask and common hands in July accounted for about 60% and 70% of the population, respectively,” the ministry said. He added that the effects showed the importance and good fortune of government awareness campaigns in recent months.
However, the study warned that spaces with lower immunity rates may be at increased risk at the time of the epidemic. As a result of this discovery, it was desired to strengthen the surveillance of sentinel sites and strengthen physical conditioning services for the Covid-19 remedy, i.e. in rural districts.
“While additional knowledge research is underway, experts have proposed conducting normal seroprevalence surveys to map evolution and exposure to Covid-19 and conduct aggregate knowledge research (combining knowledge of other such studies) conducted in Pakistan for further research.” He said the statement.
The ministry said seroprevalence studies are underway to assess what percentage of the population has developed protective immunity (antibodies) opposite the virus. He added that “findings will be used for political decisions” in the future.
High-performance product development